Gilead Sciences is buying Ouro Medicines, a startup creating T cell engagers for a variety of autoimmune illnesses. Individually, Gilead is negotiating a cope with Galapagos to share within the growth and potential commercialization of the Ouro drug.
The publish Gilead Sciences Beneficial properties an Alternative for Immune System Reset With $1.7B Ouro Acquisition appeared first on MedCity Information.
